HANGZHOU TIGERMED CO. H 1 (5HZ1) — Cash Flow Quality Index
HANGZHOU TIGERMED CO. H 1 (5HZ1) has a Cash Flow Quality Index of 1.26x as of December 2025. Operating cash flow of €1.12 Billion exceeds net income of €887.89 Million, indicating high earnings quality where cash backs reported profits. Explore 5HZ1 cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
HANGZHOU TIGERMED CO. H 1 Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for HANGZHOU TIGERMED CO. H 1 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check HANGZHOU TIGERMED CO. H 1 total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for HANGZHOU TIGERMED CO. H 1 (2021–2025)
Year-by-year earnings quality comparison for HANGZHOU TIGERMED CO. H 1. For live market cap and the full company financial profile, see 5HZ1 market cap.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.26x | €1.12 Billion | €887.89 Million | ▼ -53.5% |
| 2024 | 2.71x | €1.10 Billion | €405.14 Million | ▲ +377.0% |
| 2023 | 0.57x | €1.15 Billion | €2.03 Billion | ▼ -15.7% |
| 2022 | 0.67x | €1.36 Billion | €2.02 Billion | ▲ +35.9% |
| 2021 | 0.50x | €1.42 Billion | €2.87 Billion | — |